Russell Middaugh

Russell Middaugh, an expert in the fields of biophysical chemistry and pharmaceutical formulation, is the Takeru and Aya Higuchi Distinguished Professor in the department of Pharmaceutical Chemistry at the University of Kansas. He is also former director and current scientific advisor of the KU Macromolecule and Vaccine Stabilization Center. Prior to joining the KU faculty in 1997, he worked in Merck’s Vaccine Division and held academic posts at MIT, the University of Wyoming, and the University of Minnesota.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Vaxess Technologies

Vaxess Technologies is a venture capital and Gates Foundation-backed life science company developing novel vaccine formulations and delivery technologies based on its proprietary silk platform. They are committed to improving access to vaccines by enabling better, more stable vaccine products that can be easily delivered all over the world.


Employees

11-50

Links